Jared Gollob

Insider Reports History

Location
Watertown, MA
Signature
/s/ Bruce Jacobs, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jared Gollob:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Kymera Therapeutics, Inc. Chief Medical Officer Common Stock 110K $6.94M $63.09 Oct 15, 2025 Direct
Kymera Therapeutics, Inc. Chief Medical Officer Stock Option (Right to Buy) 0 Oct 15, 2025 Direct

Insider Reports Filed by Jared Gollob

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KYMR Kymera Therapeutics, Inc. Oct 15, 2025 8 -$3.58M 4 Oct 15, 2025 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Oct 13, 2025 5 -$184K 4 Oct 14, 2025 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Mar 3, 2025 4 -$175K 4 Mar 3, 2025 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Jul 15, 2024 7 -$1.72M 4 Jul 16, 2024 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Mar 1, 2024 5 -$140K 4 Mar 4, 2024 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Feb 27, 2024 3 -$17.2K 4 Feb 29, 2024 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Feb 9, 2024 4 -$1.54M 4 Feb 9, 2024 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Mar 1, 2023 4 -$40.2K 4 Mar 3, 2023 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. May 4, 2022 4 $33.7K 4 May 4, 2022 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Mar 1, 2022 2 $0 4 Mar 3, 2022 Chief Medical Officer
KYMR Kymera Therapeutics, Inc. Nov 1, 2021 13 -$3.51M 4 Nov 2, 2021 Chief Medical Officer